Skip to content
value.today

Neograft Technologies, Inc.

Total raised
$34 M
5 rounds on record
Latest round
$5 M
Jan 2017
First round on record
Jan 2010
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Neograft Technologies, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2017$5 MNo. 5$2 to $10 million

Neograft Technologies, Inc.: Raise no. 5, Jan 2017

Investors in this round

3 investors had bought by the notice of Jan 26, 2017: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jon McGrath · Executive Officer, Director
  • Brad Richard Petersen · Director
  • Christopher C. Petersen · Director
  • Michael Richard Tovian · Director
  • Richard C. Petersen, Jr. · Director
  • Thomas Richard Dugan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Rounded to the nearest whole dollar.”

Signed by Jon McGrath, President and CEO. Source: SEC Form D, newest notice filed Jan 26, 2017. Read the notice at the SEC.

equitySEC
Jul 2014$11 MNo. 4$10 to $50 million

Neograft Technologies, Inc.: Raise no. 4, Jul 2014

Investors in this round

6 investors had bought by the notice of Jul 14, 2014: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $11 M offered
Smallest investment taken
$44,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jon McGrath · Executive Officer, Director
  • Dugan Thomas · Director
  • John Petersen · Director
  • Paul Southworth · Director
  • Richard Petersen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jon McGrath, President and CEO. Source: SEC Form D, newest notice filed Jul 14, 2014. Read the notice at the SEC.

equitySEC
Aug 2013$4 MNo. 3$2 to $10 million

Neograft Technologies, Inc.: Raise no. 3, Aug 2013

Investors in this round

5 investors had bought by the notice of Aug 30, 2013: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
$9,662
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jon McGrath · Executive Officer, Director
  • John Petersen · Director
  • Paul Southworth · Director
  • Richard Petersen · Director
  • Thomas Dugan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jon McGrath, Ceo. Source: SEC Form D, newest notice filed Aug 30, 2013. Read the notice at the SEC.

equitySEC
Dec 2010$8 MNo. 2$2 to $10 million

Neograft Technologies, Inc.: Raise no. 2, Dec 2010

Investors in this round

7 investors had bought by the notice of Aug 11, 2011: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • F. Dietz David · Executive Officer
  • McGrath Jon · Executive Officer, Director
  • John M. Petersen · Director
  • Paul C. Southworth · Director
  • Richard C. Petersen, Jr. · Director
  • Thomas C. Dugan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jon McGrath, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Aug 11, 2011. Read the notice at the SEC.

equitySEC
Jan 2010$6 MNo. 1$2 to $10 million

Neograft Technologies, Inc.: Raise no. 1, Jan 2010

Investors in this round

3 investors had bought by the notice of Jan 25, 2010: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $8 M offered; $1 M still to sell
Smallest investment taken
$100,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David S Smith · Executive Officer
  • David W Wagner · Executive Officer, Director
  • Jon W McGrath · Executive Officer
  • Richard W Buckingham · Executive Officer, Director
  • Richard W Petersen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David S. Smith, Secretary. Source: SEC Form D, newest notice filed Jan 25, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Neograft Technologies, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2017).

    SEC Form D · Jan 2017

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jan 2017

That is all the official record says: Neograft Technologies, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Neograft Technologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 7 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Neograft Technologies, Inc.
NameRoleNamed in
Jon McGrathExecutive officerJan 2017
F. Dietz DavidExecutive officerAug 2011
McGrath JonExecutive officerAug 2011
David WagnerExecutive officerDec 2010
David S SmithExecutive officerJan 2010
David W WagnerExecutive officerJan 2010
Jon W McGrathExecutive officerJan 2010
Richard W BuckinghamExecutive officerJan 2010
Brad Richard PetersenDirectorJan 2017
Christopher C. PetersenDirectorJan 2017
Jon McGrathDirectorJan 2017
Michael Richard TovianDirectorJan 2017
Richard C. Petersen, Jr.DirectorJan 2017
Thomas Richard DuganDirectorJan 2017
Dugan ThomasDirectorJul 2014
John PetersenDirectorJul 2014
Paul SouthworthDirectorJul 2014
Richard PetersenDirectorJul 2014
Thomas DuganDirectorAug 2013
John M. PetersenDirectorAug 2011
McGrath JonDirectorAug 2011
Paul C. SouthworthDirectorAug 2011
Thomas C. DuganDirectorAug 2011
David WagnerDirectorDec 2010
Richard BuckinghamDirectorDec 2010
David W WagnerDirectorJan 2010
Richard W BuckinghamDirectorJan 2010
Richard W PetersenDirectorJan 2010